The test was done in Malaysia where 490 COVID patients with mild or moderate symptoms were randomly given either IVM or placebo between May and October 2021 for five days. So what's the outcome? No discernible difference. IVM did NOTHING, as we've told you all along. All those IVM pimps had been lying to you about how "effective" IVM had been. It never was.
In this study, out of 490 patients, 241 ended up in IVM group, and 249 in placebo control group. 52 in the IVM group and 43 in the control group have their conditions worsened to "severe disease", which defined as blood oxygen saturation falling below 95% without use of supplemental oxygen. Other outcomes, such as requiring ICU, mechanical ventilation, or mortality and adverse events, are also nearly identical.
And these are the most vulnerable, 50+ years old, with some co-morbidity conditions. I.e. the ones that most need the drug to work.
And IVM did nothing.
Younger people who are more likely to survive COVID definitely don't need IVM.
At least two other trials in 2021 (in Colombia and Argentina) ALSO confirmed that IVM did nothing.
What else did the trial show? Vaccinated patients have a significantly lower rate of severe disease. And IVM reported 60% of all adverse events, including severe diarrhea.
The conclusion is undeniable.
IVM did not reduce risk of COVID progressing to severe status.
IVM did not reduce risk of hospitalization from COVID.
IVM did not improve survival rate of COVID.
This trial is using 0.4 mg/kg of body weight for 5 days. This is actually VERY high, but they can do so because all the patients are staying in the hospital for close monitoring. AND they already suffer from high rate of adverse events.
Imagine COVIDiots self-dosing at home, under- or over-dosing, and getting the runs (loose bowels).
All for nothing.
It does not pay to be a COVIDiot.
No comments:
Post a Comment